Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

Genetic disparity between primary tumours, disseminated tumour cells, and manifest metastasis.

Stoecklein NH, Klein CA.

Int J Cancer. 2010 Feb 1;126(3):589-98. doi: 10.1002/ijc.24916. Review.

2.

Biomarkers of residual disease, disseminated tumor cells, and metastases in the MMTV-PyMT breast cancer model.

Franci C, Zhou J, Jiang Z, Modrusan Z, Good Z, Jackson E, Kouros-Mehr H.

PLoS One. 2013;8(3):e58183. doi: 10.1371/journal.pone.0058183. Epub 2013 Mar 8.

3.

Parallel progression of primary tumours and metastases.

Klein CA.

Nat Rev Cancer. 2009 Apr;9(4):302-12. doi: 10.1038/nrc2627. Review.

PMID:
19308069
4.

Genetic heterogeneity of single disseminated tumour cells in minimal residual cancer.

Klein CA, Blankenstein TJ, Schmidt-Kittler O, Petronio M, Polzer B, Stoecklein NH, Riethmüller G.

Lancet. 2002 Aug 31;360(9334):683-9.

PMID:
12241875
5.
6.

Metastatic susceptibility locus, an 8p hot-spot for tumour progression disrupted in colorectal liver metastases: 13 candidate genes examined at the DNA, mRNA and protein level.

Macartney-Coxson DP, Hood KA, Shi HJ, Ward T, Wiles A, O'Connor R, Hall DA, Lea RA, Royds JA, Stubbs RS, Rooker S.

BMC Cancer. 2008 Jul 1;8:187. doi: 10.1186/1471-2407-8-187.

7.

From latent disseminated cells to overt metastasis: genetic analysis of systemic breast cancer progression.

Schmidt-Kittler O, Ragg T, Daskalakis A, Granzow M, Ahr A, Blankenstein TJ, Kaufmann M, Diebold J, Arnholdt H, Muller P, Bischoff J, Harich D, Schlimok G, Riethmuller G, Eils R, Klein CA.

Proc Natl Acad Sci U S A. 2003 Jun 24;100(13):7737-42. Epub 2003 Jun 13.

8.

Prognostic value of genomic alterations in minimal residual cancer cells purified from the blood of breast cancer patients.

Austrup F, Uciechowski P, Eder C, Böckmann B, Suchy B, Driesel G, Jäckel S, Kusiak I, Grill HJ, Giesing M.

Br J Cancer. 2000 Dec;83(12):1664-73. Erratum in: Br J Cancer 2001 Mar 23;84(6):874.

9.
10.

Using tumour phylogenetics to identify the roots of metastasis in humans.

Naxerova K, Jain RK.

Nat Rev Clin Oncol. 2015 May;12(5):258-72. doi: 10.1038/nrclinonc.2014.238. Epub 2015 Jan 20. Review.

11.

Functional and molecular characterisation of EO771.LMB tumours, a new C57BL/6-mouse-derived model of spontaneously metastatic mammary cancer.

Johnstone CN, Smith YE, Cao Y, Burrows AD, Cross RS, Ling X, Redvers RP, Doherty JP, Eckhardt BL, Natoli AL, Restall CM, Lucas E, Pearson HB, Deb S, Britt KL, Rizzitelli A, Li J, Harmey JH, Pouliot N, Anderson RL.

Dis Model Mech. 2015 Mar;8(3):237-51. doi: 10.1242/dmm.017830. Epub 2015 Jan 29.

12.

The biology and analysis of single disseminated tumour cells.

Klein CA.

Trends Cell Biol. 2000 Nov;10(11):489-93. Review.

PMID:
11050421
13.

The expression of p53, bcl-2, bax, fas and fasL in the primary tumour and lymph node metastases of breast cancer.

Sjöström-Mattson J, Von Boguslawski K, Bengtsson NO, Mjaaland I, Salmenkivi K, Blomqvist C.

Acta Oncol. 2009;48(8):1137-43. doi: 10.3109/02841860902988688.

PMID:
19863221
14.

Host genetics and tumour metastasis.

Hunter KW.

Br J Cancer. 2004 Feb 23;90(4):752-5. Review.

15.

Cellular and molecular background underlying the diversity in therapeutic responses between primary tumours and metastases.

Romano S, D'Angelillo A, Romano A, Nappo G, Romano MF.

Curr Med Chem. 2014;21(14):1631-8. Review.

PMID:
23992331
16.

Molecular phenotyping of circulating tumour cells in patients with prostate cancer: prediction of distant metastases.

Giesing M, Driesel G, Molitor D, Suchy B.

BJU Int. 2012 Dec;110(11 Pt C):E1202-11. doi: 10.1111/j.1464-410X.2012.11534.x. Epub 2012 Oct 9.

17.

The direct molecular analysis of metastatic precursor cells in breast cancer: a chance for a better understanding of metastasis and for personalised medicine.

Klein CA.

Eur J Cancer. 2008 Dec;44(18):2721-5. doi: 10.1016/j.ejca.2008.09.035. Epub 2008 Nov 18. Review.

PMID:
19022661
18.

Molecular genetics of metastasis.

Tarin D.

Ciba Found Symp. 1988;141:149-69. Review.

PMID:
3075933
19.

Self-renewal gene tracking to identify tumour-initiating cells associated with metastatic potential.

Darini CY, Pisani DF, Hofman P, Pedeutour F, Sudaka I, Chomienne C, Dani C, Ladoux A.

Oncogene. 2012 May 10;31(19):2438-49. doi: 10.1038/onc.2011.421. Epub 2011 Sep 19.

PMID:
21927026
20.

Analysis of neuroblastoma tumour progression; loss of PHOX2B on 4p13 and 17q gain are early events in neuroblastoma tumourigenesis.

Krona C, Carén H, Sjöberg RM, Sandstedt B, Laureys G, Kogner P, Martinsson T.

Int J Oncol. 2008 Mar;32(3):575-83.

PMID:
18292934

Supplemental Content

Support Center